InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+13.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by GOYAL ARJUN, Director. Officer active across 1 company, notably Centessa Pharmaceuticals plc. Aggregated, 4 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €492k. Activity tracked since 15 May 2025. The latest transaction was filed on 15 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
462,585 sharesOrdinary SharesSEC:0001470831-26-000613:0
44,939 shares@ US$12.2441100.0% of flowOrdinary SharesSEC:0001847903-25-000074:0
Ideal exit: 9 Feb 2026 (T+270)
3,095,909 sharesOrdinary SharesSEC:0000899243-21-022066:0
3,095,909 sharesOrdinary SharesSEC:0000899243-21-022066
4 of 4 declarations
About GOYAL ARJUN
Arjun Goyal is a Director at Centessa Pharmaceuticals plc. In this role, he brings his expertise in corporate governance and strategy. His experience in the pharmaceutical sector allows him to effectively contribute to strategic decisions and the direction of Centessa Pharmaceuticals, ensuring its development and compliance.
